Setup, so nobody has to ask: GL Biochem · Qingdao Saber Technology.
I am trying to choose between two options that are usually discussed as though only one exists.
I am not optimising for price, but I am not indifferent to it either.
So which one, and on what grounds?
The relevant point is that two competent laboratories disagree by half a per cent on identical material, which is larger than most of the differences people argue about.
Cost per milligram of actual peptide is the honest price comparison, which means dividing by measured content rather than by label claim.
Lead time and lane behaviour are supplier properties too and are easier to compare than analytical ones, because they need no laboratory at all.
Content assay results across the published datasets vary considerably more between suppliers than purity does, which makes content the more discriminating axis.
Price per milligram of measured peptide, not per milligram of label claim.
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse resultsThe honest answer is that most claimed differences between reputable suppliers are inside inter-laboratory noise.
To compare properly: order the same compound at the same nominal strength from each supplier, submit all samples to the same laboratory in the same submission if possible, and ask for the same test set on each.
Put another way, sample size matters. One order each is an anecdote about six vials; three orders each over a year is the beginning of a comparison.
Use a fixed documentation checklist rather than an impression.
Answering this needs the axis. A supplier that is best on paperwork and a supplier that is best on price are both correct answers to different questions.
Content is the more discriminating measurement than purity for supplier comparison, because purity clusters tightly among competent suppliers and content does not.
Submitting to different laboratories introduces a method difference that commonly exceeds the supplier difference. Gradient slope alone can move a reported purity figure by a per cent in either direction.
The ratings on this site are a community opinion average on a ten-point scale and are not reconciled with any other community's figures.
The caveat is that a comparison is a snapshot of the lots compared, and lots change.
One laboratory, one method, one submission. Otherwise it is not a comparison.
Stated carefully, ratings on this site are ours alone and are deliberately not reconciled with anyone else's.
Publish the method with the result. A comparison without the laboratory named and the submission dates given is not reproducible by anyone.
Nothing here is medical advice, and research-use compounds are not approved for human use.
Name the laboratory and the dates or the comparison cannot be reproduced.
Answer first: comparing suppliers is only meaningful if the comparison holds the laboratory, the method and the compound constant, and most published comparisons hold none of them.
Compare documentation on a fixed checklist rather than by impression: lot specificity, method section, chromatogram availability, quantified content, water and counter-ion figures, and whether the code is on the vial.
Inter-laboratory spread on identical peptide material is routinely half a per cent to a per cent by RP-HPLC, which is the noise floor for any cross-laboratory comparison.
Comparisons drawn from different laboratories at different times are weaker evidence than most people treat them as.
Compare content, not purity. Purity clusters and content does not.
edited 20 Aug 2026 by w_okoye — added the citation requested in comments
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.